Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
58 hedge funds and large institutions have $62.3M invested in Marrone Bio Innovations, Inc. in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 21 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
6% more capital invested
Capital invested by funds: $59M → $62.3M (+$3.31M)
4% more funds holding
Funds holding: 56 → 58 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
43% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$417K |
| 2 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$375K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$210K |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$166K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$56.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
-$188K |
| 2 |
BlackRock
New York
|
-$60.4K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$44.4K |
| 4 |
SG Americas Securities
New York
|
-$43K |
| 5 |
SIM
Spark Investment Management
New York
|
-$39K |
MBII Hedge Fund Activity: Q3 2020 in Review
58 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q3 2020, worth a combined $62.3M — up 5.6% from $59M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new MBII positions and 4 closed out — a net gain of 2 holders — while 12 added to existing stakes and 21 trimmed.
The largest buyer was Ardsley Advisory Partners, adding an estimated $417K. The largest seller was Primecap Management, cutting an estimated $188K.
- 58 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q3 2020, up from 56 in Q2 2020.
- Funds reported $62.3M of Marrone Bio Innovations, Inc. stock for Q3 2020, up 5.6% quarter-over-quarter.
- 6 funds opened new Marrone Bio Innovations, Inc. positions in Q3 2020 and 4 closed out, a net change of +2 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q3 2020 was Ardsley Advisory Partners, an estimated $417K added.
- The largest Marrone Bio Innovations, Inc. seller in Q3 2020 was Primecap Management, an estimated $188K sold.
Based on aggregated 13F filings for Q3 2020.